Jan Lundahl, senior partner at CapMan, has stepped down as head of CapMan Life Science and left the buyout firm's management group. He will be replaced by Johan Bennarsten who is currently deputy head of the division.
Deal is the first add-on since Main Capital acquired it in June 2019
Fund invests in North American and European businesses operating across the financial services sector
New funding will be used to accelerate growth in new markets such as Asia-Pacific and Latin America
Team includes partners Oliver Rochman and Rob Mailer, and two associates